188 related articles for article (PubMed ID: 32203146)
1. Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.
Husby S; Favero F; Nielsen C; Sørensen BS; Bæch J; Grell K; Hansen JW; Rodriguez-Gonzalez FG; Haastrup EK; Fischer-Nielsen A; Andersen P; Arboe B; Sækmose SG; Hansen PB; Christiansen I; Clasen-Linde E; Meldgaard L; Ebbesen LH; Segel EK; Josefsson P; Thorsgaard M; El-Galaly TC; Brown P; Weischenfeldt J; Larsen TS; Grønbæk K
Leukemia; 2020 Dec; 34(12):3256-3268. PubMed ID: 32203146
[TBL] [Abstract][Full Text] [Related]
2. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
Lackraj T; Ben Barouch S; Medeiros JJF; Pedersen S; Danesh A; Bakhtiari M; Hong M; Tong K; Joynt J; Arruda A; Minden MD; Kuruvilla J; Bhella S; Kukreti V; Crump M; Prica A; Chen C; Deng Y; Xu W; Pugh TJ; Keating A; Dick JE; Abelson S; Kridel R
Am J Hematol; 2022 Dec; 97(12):1538-1547. PubMed ID: 36087071
[TBL] [Abstract][Full Text] [Related]
4. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
5. Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation.
Levis M; Piva C; Filippi AR; Botto B; Gavarotti P; Pregno P; Nicolosi M; Freilone R; Parvis G; Gottardi D; Vitolo U; Ricardi U
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):14-22. PubMed ID: 27727134
[TBL] [Abstract][Full Text] [Related]
6. The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma.
Madle M; Krämer I; Lehners N; Schwarzbich M; Wuchter P; Herfarth K; Egerer G; Ho AD; Witzens-Harig M
Ann Hematol; 2015 Nov; 94(11):1853-7. PubMed ID: 26268792
[TBL] [Abstract][Full Text] [Related]
7. Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
Sun L; Li S; El-Jawahri A; Armand P; Dey BR; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; McAfee SL; Spitzer TR; Chen YB; DeFilipp Z
Oncologist; 2018 May; 23(5):624-630. PubMed ID: 29284757
[TBL] [Abstract][Full Text] [Related]
8. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Ortmann CA; Dorsheimer L; Abou-El-Ardat K; Hoffrichter J; Assmus B; Bonig H; Scholz A; Pfeifer H; Martin H; Schmid T; Brüne B; Scheich S; Steffen B; Riemann J; Hermann S; Dukat A; Bug G; Brandts CH; Wagner S; Serve H; Rieger MA
Cell Rep; 2019 May; 27(7):2022-2028.e3. PubMed ID: 31091442
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
Mouhieddine TH; Sperling AS; Redd R; Park J; Leventhal M; Gibson CJ; Manier S; Nassar AH; Capelletti M; Huynh D; Bustoros M; Sklavenitis-Pistofidis R; Tahri S; Hornburg K; Dumke H; Itani MM; Boehner CJ; Liu CJ; AlDubayan SH; Reardon B; Van Allen EM; Keats JJ; Stewart C; Mehr S; Auclair D; Schlossman RL; Munshi NC; Anderson KC; Steensma DP; Laubach JP; Richardson PG; Ritz J; Ebert BL; Soiffer RJ; Trippa L; Getz G; Neuberg DS; Ghobrial IM
Nat Commun; 2020 Jun; 11(1):2996. PubMed ID: 32533060
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.
Kassam S; Chernucha E; O'Neill A; Hemmaway C; Cummins T; Montoto S; Lennard A; Adams G; Linton K; McKay P; Davies D; Rowntree C; Easdale S; Eyre TA; Marcus R; Cwynarski K; Fox CP
Bone Marrow Transplant; 2017 Sep; 52(9):1268-1272. PubMed ID: 28581466
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Kerndrup GB; Hansen MC; Ewald IKL; Bill M; Ebbesen LH; Rosenberg CA; Hokland P; Ludvigsen M; Stidsholt Roug A
Blood Adv; 2020 Mar; 4(5):885-892. PubMed ID: 32150606
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Zhang H; Graiser M; Hutcherson DA; Dada MO; McMillan S; Ali Z; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1287-94. PubMed ID: 22370160
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma.
Okay M; Büyükaşık Y; Demiroğlu H; Malkan ÜY; Çiftçiler R; Aladağ E; Aksu S; Haznedaroğlu İC; Sayınalp N; Özcebe Oİ; Göker H
Turk J Med Sci; 2019 Aug; 49(4):985-992. PubMed ID: 31293116
[TBL] [Abstract][Full Text] [Related]
15. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.
Nagayama T; Ashizawa M; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Ann Hematol; 2020 Dec; 99(12):2893-2901. PubMed ID: 32572522
[TBL] [Abstract][Full Text] [Related]
16. Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.
Madsen C; Pedersen MB; Vase MØ; Bendix K; Møller MB; Johansen P; Jensen BA; Jensen P; Munksgaard L; Brown PD; Segel EK; d'Amore FA
Ann Oncol; 2015 Feb; 26(2):393-9. PubMed ID: 25411416
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
18. Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.
Hunter BD; Herr M; Meacham PJ; Barlaskar F; Evans AG; Burack WR; Liesveld JL; Becker MW; Milner LA; Constine LS; Dhakal S; Barr PM; Friedberg JW; Casulo C
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):145-151. PubMed ID: 27998707
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Olivieri J; Mosna F; Pelosini M; Fama A; Rattotti S; Giannoccaro M; Carli G; Tisi MC; Ferrero S; Sgherza N; Mazzone AM; Marino D; Calimeri T; Loseto G; Saraceni F; Tomei G; Sica S; Perali G; Codeluppi K; Billio A; Olivieri A; Orciuolo E; Matera R; Stefani PM; Borghero C; Ghione P; Cascavilla N; Lanza F; Chiusolo P; Finotto S; Federici I; Gherlinzoni F; Centurioni R; Fanin R; Zaja F;
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1814-1822. PubMed ID: 29857196
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
